GPR41 and modulators thereof for the treatment of insulin-related disorders

Details for Australian Patent Application No. 2005305083 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Chu, Zhi Liang; Boatman, P. Douglas; Leonard, James N.; Bruce, Marc A.

Agent FB Rice

Pub. Number AU-B-2005305083

PCT Pub. Number WO2006/052566

Priority 60/624,867 03.11.04 US

Filing date 1 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 2 February 2012

International Classifications

A61K 49/00 (2006.01) Preparations for testing

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052566 Priority application(s): WO2006/052566

2 February 2012 Application Accepted

  Published as AU-B-2005305083

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305086-Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists

2005305082-Method and apparatus for managing wireless communication network radio resources